首页> 外文期刊>Journal of affective disorders >Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls
【24h】

Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls

机译:与对照组相比,患有重度抑郁症的药物患者的血清脱氢表雄酮(DHEA)和硫酸DHEA(S)水平

获取原文
获取原文并翻译 | 示例
           

摘要

Background: There is accumulating evidence regarding gender differences in clinical symptoms or response to antidepressants in patients with depression. However, less attention has been given to sex differences in the underlying biological mechanisms of depression. The adrenal androgens, dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEA-S), play a critical role in controlling affect, mood, and anxiety. Changes in serum adrenal androgen levels have been reported in conditions pertaining to stress as well as in psychiatric disorders. The objective of the present study was to investigate differences in serum levels of adrenal androgens in male and female patients with major depressive disorder (MDD). Methods: Participants included 90 inpatients with MDD at the psychiatric ward of Juntendo University Koshigaya Hospital who were receiving antidepressants. Serum levels of DHEA and DHEA-S were assessed at the time of admission. Matched controls (based on sex and age) included 128 healthy individuals. First, data from male and female MDD patients and controls were compared. Second, correlations between serum hormone levels and scores on the Hamilton Rating Scale for Depression (HAM-D) of patients with MDD were assessed by gender. In addition, effects of various factors on adrenal androgens were analyzed using multiple regression analysis. Results: Serum DHEA levels were significantly increased in both male and female MDD patients compared with controls. Serum levels of DHEA-S in male patients were significantly decreased compared with male controls, whereas no significant differences were seen in female patients and controls. No significant correlations among adrenal androgens were observed in male patients with MDD, whereas significant positive correlations were found in both male and female controls. No significant correlations were seen between adrenal androgens and HAM-D scores in male or female patients. Multiple regression analysis showed that both hormones were affected by the age at onset of depression. Limitations: All subjects in the present study were on antidepressant medications. Conclusions: Elevated levels of serum DHEA may be associated with the biological pathophysiology of depression, as DHEA administration has been found to be effective for the treatment of depression. Findings of differential changes in DHEA-S levels in men compared with women may suggest distinct characteristics of these hormones between men and women with depression. However, DHEA/DHEA-S may be a poor indicator for evaluating severity of depression. ? 2012 Elsevier B.V. All rights reserved.
机译:背景:越来越多的证据表明抑郁症患者的临床症状或对抗抑郁药的反应存在性别差异。但是,人们对抑郁症的潜在生物学机制中的性别差异的关注较少。肾上腺雄激素,脱氢表雄酮(DHEA)及其硫酸盐衍生物(DHEA-S)在控制情感,情绪和焦虑中起关键作用。据报道,在与压力以及精神疾病有关的疾病中,血清肾上腺雄激素水平发生了变化。本研究的目的是调查患有严重抑郁症(MDD)的男性和女性患者的肾上腺雄激素的血清水平差异。方法:参加者包括在顺天堂大学越谷医院精神病房接受抗抑郁药治疗的90名MDD患者。入院时评估血清DHEA和DHEA-S的水平。匹配的对照(基于性别和年龄)包括128位健康个体。首先,比较了男性和女性MDD患者和对照组的数据。其次,通过性别评估血清激素水平与MDD患者汉密尔顿抑郁量表(HAM-D)得分之间的相关性。此外,使用多元回归分析分析了各种因素对肾上腺雄激素的影响。结果:男性和女性MDD患者的血清DHEA水平均显着高于对照组。与男性对照组相比,男性患者的血清DHEA-S水平显着降低,而女性患者和对照组则没有显着差异。在男性MDD患者中未观察到肾上腺雄激素之间的显着相关性,而在男性和女性对照中均发现显着的正相关性。男性或女性患者的肾上腺雄激素与HAM-D评分之间无显着相关性。多元回归分析表明,两种激素均受抑郁症发作年龄的影响。局限性:本研究中的所有受试者均接受抗抑郁药治疗。结论:血清DHEA水平升高可能与抑郁症的生物学病理生理有关,因为已发现DHEA可以有效治疗抑郁症。男性与女性相比,DHEA-S水平差异变化的发现可能表明,患有抑郁症的男性和女性之间这些激素的特征不同。但是,DHEA / DHEA-S可能不是评估抑郁严重程度的不良指标。 ? 2012 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号